Results 11 to 20 of about 2,371,082 (294)

Quality assessment of nine paracetamol 500 mg tablet brands marketed in Saudi Arabia

BMC Research Notes, 2021
Objective To evaluate in-vitro quality of paracetamol 500 mg tablet brands marketed in Saudi Arabia. Results Two reference (R1 and R2) and seven generic (G1-G7) brands were commercially available. Four brands were single-drug, containing paracetamol only
Reem AlSwayeh, Syed N. Alvi, Muhammad M. Hammami   +2 more
doaj   +1 more source

Aggressiveness of care in the last days of life in the emergency department of a tertiary hospital in Korea

BMC Palliative Care, 2022
Background High-quality end-of-life (EOL) care requires both comfort care and the maintenance of dignity. However, delivering EOL in the emergency department (ED) is often challenging.
Jung Sun Kim, Sun Young Lee, Min Sung Lee, Shin Hye Yoo, Jeongmi Shin, Wonho Choi, Yejin Kim, Hyung Sook Han, Jinui Hong, Bhumsuk Keam, Dae Seog Heo   +10 more
doaj   +1 more source

Commented review of the Colombian legislation regarding the ethics of health research

Biomédica: revista del Instituto Nacional de Salud, 2017
The scope of ethics in health research transcends its legal framework and the regulations established in Resolution 8430 of 1993. These norms represent a fundamental tool to determine the minimum protection standards for research subjects, and, therefore,
Mónica María Lopera
doaj   +1 more source

Evaluating assessment tools of the quality of clinical ethics consultations: a systematic scoping review from 1992 to 2019

BMC Medical Ethics, 2020
Background Amidst expanding roles in education and policy making, questions have been raised about the ability of Clinical Ethics Committees (CEC) s to carry out effective ethics consultations (CECons).
Nicholas Yue Shuen Yoon, Yun Ting Ong, Hong Wei Yap, Kuang Teck Tay, Elijah Gin Lim, Clarissa Wei Shuen Cheong, Wei Qiang Lim, Annelissa Mien Chew Chin, Ying Pin Toh, Min Chiam, Stephen Mason, Lalit Kumar Radha Krishna   +11 more
doaj   +1 more source

Deciding the Criteria Is Not Enough: Moral Issues to Consider for a Fair Allocation of Scarce ICU Resources

Philosophies, 2022
During the first wave of the COVID-19 pandemic in Italy, practitioners had to make tragic decisions regarding the allocation of scarce resources in the ICU.
Davide Battisti, Mario Picozzi
doaj   +1 more source

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs

BMC Pharmacology and Toxicology, 2017
Background The extents of generic-reference and generic-generic average bioequivalence and intra-subject variation of on-market drug products have not been prospectively studied on a large scale.
Muhammad M. Hammami, Sophia J. S. De Padua, Rajaa Hussein, Eman Al Gaai, Nesrine A. Khodr, Reem Al-Swayeh, Syed N. Alvi, Nada Binhashim   +7 more
doaj   +1 more source

Pharmaceutical quality of seven brands of diclofenac tablet on the Saudi market

BMC Research Notes, 2020
Objective We previously reported the pharmaceutical quality of eight brands of 50 mg enteric-coated diclofenac sodium tablet available on the Saudi market.
Muhammad M. Hammami, Reem AlSwayeh, Rajaa F. Hussein   +2 more
doaj   +1 more source

Comparison of analog and digital patient decision aids for the treatment of depression: a scoping review

Frontiers in Digital Health, 2023
IntroductionPatient decision aids (PDAs) are important tools to empower patients and integrate their preferences and values in the decision-making process.
Jana Sedlakova, Anna Lisa Westermair, Anna Lisa Westermair, Anna Lisa Westermair, Nikola Biller-Andorno, Christoph A. Meier, Christoph A. Meier, Manuel Trachsel, Manuel Trachsel, Manuel Trachsel   +9 more
doaj   +1 more source

Clinical ethics consultations: a scoping review of reported outcomes

BMC Medical Ethics, 2022
Background Clinical ethics consultations (CEC) can be complex interventions, involving multiple methods, stakeholders, and competing ethical values. Despite longstanding calls for rigorous evaluation in the field, progress has been limited.
Jennifer A. H. Bell, Marina Salis, Eryn Tong, Erica Nekolaichuk, Claudia Barned, Andria Bianchi, Daniel Z. Buchman, Kevin Rodrigues, Ruby R. Shanker, Ann M. Heesters   +9 more
doaj   +1 more source

Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design

BMC Medical Research Methodology, 2016
Background Conventional randomized placebo-controlled study design assumes the absence of drug*placebo interaction. We hypothesized the presence of such an interaction and that conventionally estimated drug effect might be biased.
Muhammad M. Hammami, Safa Hammami, Reem Al-Swayeh, Eman Al-Gaai, Faduma Abdi Farah, Sophia J. S. De Padua   +5 more
doaj   +1 more source